Key takeaways:
Researchers identified no link between vaginal estrogen tablet use and recurrent stroke risk.
The findings did not vary by current or past use or by therapy dose.
No link between vaginal estrogen tablet use and recurrent stroke was observed in a cohort of women with a history of stroke, regardless of current or past use of the hormone therapy or dose, researchers reported.
Results from a Danish nationwide study evaluating the impact of vaginal estradiol on recurrent stroke risk was published in Stroke .
Researchers identified no link between vaginal estrogen tablet use and recurrent stroke risk. Image: Adobe Stock
“It is well known that taking systemic hormone replacement therapy, such as oral estrogen tablets, may increase the risk of stroke after menopause. While